• The retinal toxicity of human tissue plasminogen activator in normal rabbit eyes has recently been reported. We now report the retinal toxicity of tissue plasminogen activator in three groups of vitrectomized rabbit eyes. Group 1 underwent gas compression of the vitreous followed by tissue plasminogen activator injection in doses of 25, 50, and 100 μg (all doses were administered in 100 μL of fluid). Group 2 underwent lensectomy and vitrectomy followed by tissue plasminogen activator injection of 100 μg. Group 3 underwent lensectomy, vitrectomy, and complete fluid/gas exchange prior to injections of 12.5 and 25 μg of tissue plasminogen activator. Control eyes received 100 μL of balanced salt solution. In group 1, no retinal toxic reactions were observed after administration of 25 or 50 μg of tissue plasminogen activator, but all eyes receiving 100 μg demonstrated retinal damage on ophthalmoscopy, electroretinography, and light microscopy. In group 2, no retinal toxic reactions were seen after administration of 100 μg of tissue plasminogen activator. In group 3, two of 11 eyes receiving 25 μg of tissue plasminogen activator demonstrated toxic retinal changes by ophthalmoscopy, electroretinography, and light microscopy. These results suggest that gas compression of the vitreous does not significantly alter the toxic changes seen caused by tissue plasminogen activator. While lensectomy and vitrectomy appears to widen the therapeutic window for tissue plasminogen activator, the margin of safety is reduced with the addition of a large gas bubble.
Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal Toxicity of Human Tissue Plasminogen Activator in Vitrectomized Rabbit Eyes. Arch Ophthalmol. 1991;109(5):718–722. doi:10.1001/archopht.1991.01080050134044
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.